08:00 , Feb 11, 2002 |  BC Week In Review  |  Company News

Balance management update

Balance Pharmaceuticals Inc., Santa Monica, Calif.   Business: Reproductive   Hired: Kathleen Hurtado as CEO, formerly CBO and VP of corporate development at Xcyte Therapies Inc.  ...
07:00 , Aug 14, 2000 |  BC Week In Review  |  Company News

Balance management update

Balance Pharmaceuticals Inc. , Santa Monica, Calif.   Business: Reproductive   Hired: David Flamberg as VP of manufacturing and quality systems, formerly VP of compliance at NexStar Pharmaceuticals Inc.  ...
07:00 , Jul 3, 2000 |  BC Week In Review  |  Clinical News

Deslorelle nasal mist: Phase II data; Phase II/III

Data from a 3-month study in 66 patients showed that daily administration of deslorelin reduced heavy bleeding associated with uterine fibroids. The product is in a 26-month Phase II/III study in 240 premenopausal women to...
07:00 , Jul 3, 2000 |  BC Week In Review  |  Company News

Balance scientific advisory board update

Balance Pharmaceuticals Inc., Santa Monica, Calif.   Business: Reproductive   Appointed: Mark Hornstein, associate professor at Harvard University and associate director of the department of obstetrics and gynecology at Brigham and Women. s Hospital; and...
08:00 , Dec 8, 1997 |  BC Week In Review  |  Company News

Cohesion Corp. board of directors update

Cohesion Corp., Palo Alto, Calif.   Business: Biomaterial/Skin/Wound   Appointed: John Daniels, chairman and CEO of Balance Pharmaceuticals Inc. , as chairman; Reid Dennis, general partner at Institutional Venture Partners; and Craig Johnson, director of...
07:00 , Oct 14, 1996 |  BioCentury  |  Emerging Company Profile

Balance Pharmaceuticals Inc.

Balance Pharmaceuticals Inc. Santa Monica, Calif. Technology: Hormone-based combination therapy Disease focus: Women's health Clinical status: Completed Phase I trial of DE2T nasal spray Founded: 1992 by Darcy Spicer, Malcolm Pike and John Daniels Corporate...
07:00 , Oct 14, 1996 |  BioCentury  |  Emerging Company Profile

Balance: Fast to market in women's health

Balance: Fast to market in women's health Addressing the opportunity to develop needed products for women's health, Balance Pharmaceuticals Inc. is implementing a fast-to-market development strategy using approved drugs in new delivery systems. Founded in...